news
12-29-2012, 01:55 AM
Eliquis is the third anticlotting medicine to be approved recently and it is expected the backers will aggressively market their products.http://rss.nytimes.com/c/34625/f/642562/s/270688a9/mf.gif
More... (http://www.nytimes.com/2012/12/29/business/fda-approves-eliquis-from-bristol-and-pfizer.html?partner=rss&emc=rss)
More... (http://www.nytimes.com/2012/12/29/business/fda-approves-eliquis-from-bristol-and-pfizer.html?partner=rss&emc=rss)